Karjalainen, Marjo J., Pertti J. Neuvonen, and Janne T. Backman.
"ROFECOXIB IS A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP1A2 - IMPLICATIONS FOR IN VITRO PREDICTION OF DRUG INTERACTIONS." Drug Metabolism and Disposition
(2006):
.
Web. 23 April. 2024.